shares of amylyx pharmaceuticals inc inc amlx soared 216 in premarket trading on friday after the company said us regulators extended the review time for its experimental amyotrophic lateral sclerosis treatment the new prescription drug user fee act date is sept 29 amylyxs stock is down 624 over the last three months while the sp 500 spx has declined 48